SCHEMBL6809361

SCHEMBL6809361

O=C(NCc1ccccc1)NCc1ccc(Nc2cc(C(F)(F)F)ccc2Nc2ccccc2C(=O)O)c(C(=O)O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 8/20 0.57
AKR1B1 P15121 1/20 0.55
AKR1C4 P17516 1/20 0.55
AKR1C3 P42330 1/20 0.55
AKR1C2 P52895 1/20 0.55
AKR1C1 Q04828 1/20 0.55
CFD P00746 1/20 0.51
GRIK1 P39086 1/20 0.45
RXFP1 Q9HBX9 1/20 0.43
SORT1 Q99523 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LIPC P11150 1/20 0.43
LIPG Q9Y5X9 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ASPH Q12797 1/20 0.43
RIOX2 Q8IUF8 1/20 0.43
KDM8 Q8N371 1/20 0.43
MPO P05164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809409 0.93 TAS2R14 (0.56) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
SCHEMBL6140781 0.91 TAS2R14 (0.59) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
SCHEMBL6140963 0.88 TAS2R14 (0.55) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
Hydrochloric Acid SCHEMBL6140941 0.85 TAS2R14 (0.55) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
Hydrochloric Acid SCHEMBL6141263 0.85 TAS2R14 (0.54) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
Hydrochloric Acid SCHEMBL6141251 0.85 TAS2R14 (0.49) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
SCHEMBL6141255 0.84 TAS2R14 (0.61) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
SCHEMBL6141209 0.84 TAS2R14 (0.61) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
SCHEMBL6813056 0.84 TAS2R14 (0.77) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2
Hydrochloric Acid SCHEMBL6140912 0.84 TAS2R14 (0.60) TAS2R14AKR1B1AKR1C4AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142993-A1 Inhibitors of HCV NS5B polymerase PHARMACIA & UPJOHN COMPANY 2004-07-22 US claimed
US-20040142993-A1 Inhibitors of HCV NS5B polymerase PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142993-A1 Inhibitors of HCV NS5B polymerase POLRMT, POLR1E, CTDSP1 TAS2R14 4336/4885AKR1B1 2012/4885AKR1C4 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.